Insecticides (India) Limited (532851) Earnings Call Transcripts

23 earnings calls from February 2020 to May 28, 2026

BSE IN Materials Chemicals

Insecticides (India) Limited's Latest Earnings Call - Q4 FY2026

Insecticides (India) Limited reported a steady performance for Q4 FY '26, with revenue increasing 19% year-over-year, driven by both B2C and B2B segments. For the full fiscal year, revenue rose to INR 2,140 crores, a 7% increase, while net profit slightly declined to INR 139 crores due to higher tax provisions. Management remains cautiously optimistic about FY '27, indicating potential for continued growth despite challenges in raw material pricing and geopolitical tensions.

Reported metrics

MetricValueContext
Revenue INR 2,140 crores (beat) vs INR 2,000 crores last year, +7% YoY
Net Profit INR 139 crores (miss) vs INR 142 crores last year, -2% YoY
Gross Profit Margin 31.5% (beat) vs 23.1% last year, +8.4% YoY
EBITDA INR 227 crores (beat) vs INR 221 crores last year, +3% YoY
ROCE 16.1% (beat) vs 10.4% last year, +5.7% YoY
Volume Growth (Q4) 5% (inline) vs previous quarter

Guidance from management

Management remains cautiously optimistic about FY '27, expecting decent growth supported by pricing actions and improved demand visibility as the season progresses. They indicated that the CapEx requirement will remain nominal at INR 25-30 crores.

What management said

Yes, that's correct actually provided we are able to encash that. So there is every effort that we should take the advantage of the current situation because we generally start our planning from Diwali and this Diwali to Holi exercise whatever we buy and whatever we [indiscernible] et cetera. So yes, this year, since the prices have gone up, so this will be particularly helpful. So we are keeping the finger crossed f...
— Rajesh Aggarwal, Q4 FY2026 earnings call
Yes, that's very, very important actually, and we are trying to build up the brand in that fashion so that we are able to attract the CDMO relationships. So already there are certain things which are in the initial stages and there will be some small supplies which will be going to trial purposes. So when I say trials, trials that we won contingent trials also. So we have to build that relationship stronger and we ha...
— Rajesh Aggarwal, Q4 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the impact of rising raw material costs on margins and the company's ability to maintain profitability amidst geopolitical tensions. There were also questions about the effectiveness of inventory management strategies and the potential for unsold inventory.

Main topics on the call

Read the full Insecticides (India) Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Insecticides (India) Limited

Insecticides (India) Limited (532851) is a publicly listed company in the Chemicals industry, within the Materials sector. It trades on BSE and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 23 calls on record spanning February 10, 2020 to May 28, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 23 Insecticides (India) Limited earnings call transcripts on record, spanning February 10, 2020 to May 28, 2026. Based on this history, Insecticides (India) Limited reports quarterly. The most recent call on file is dated May 28, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
532851
Exchange
BSE
Country
IN
Sector
Materials
Industry
Chemicals
Calls on record
23
First call
February 10, 2020
Most recent
May 28, 2026
Reporting cadence
quarterly
Quarter Date
Q4 FY2026 May 28, 2026 Read transcript
Q4 FY2025 May 28, 2025 Read transcript
Q3 FY2025 Feb 10, 2025 Read transcript
Q2 FY2025 Nov 12, 2024 Read transcript
Q1 FY2025 Aug 9, 2024 Read transcript
Q4 FY2024 May 29, 2024 Read transcript
Q3 FY2024 Feb 6, 2024 Read transcript
Q2 FY2024 Nov 3, 2023 Read transcript
Q1 FY2024 Aug 11, 2023 Read transcript
Q4 FY2023 May 31, 2023 Read transcript
Q3 FY2023 Feb 14, 2023 Read transcript
Q2 FY2023 Nov 8, 2022 Read transcript
Q1 FY2023 Aug 17, 2022 Read transcript
Q4 FY2022 May 27, 2022 Read transcript
Q3 FY2022 Feb 11, 2022 Read transcript
Q2 FY2022 Nov 16, 2021 Read transcript
Q1 FY2022 Aug 11, 2021 Read transcript
Q4 FY2021 Jun 21, 2021 Read transcript
Q3 FY2021 Feb 8, 2021 Read transcript
Q2 FY2021 Nov 10, 2020 Read transcript
Q1 FY2021 Aug 17, 2020 Read transcript
Q4 FY2020 Jun 26, 2020 Read transcript
Q3 FY2020 Feb 10, 2020 Read transcript